[{"target":111,"price":23.670,"returns":369,"ticker":"NFX","note":"Analysts Set Valero Energy Co. (VLO) Price Target at $111.94 - PressOracle","to_char":"03/15/2019","q_eps":null,"a_eps":0.000,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":119,"price":29.700,"returns":301,"ticker":"MCS","note":"Brokerages Set McCarthy & Stone PLC (MCS) Target Price at $119.00 - Fairfield Current","to_char":"03/14/2019","q_eps":null,"a_eps":1.860,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":50,"price":25.290,"returns":98,"ticker":"DCPH","note":"Professional Analysts at Canaccord Genuity Maintain their Buy rating for Deciphera Pharmaceuticals (DCPH). The Target Given is $50","to_char":"03/15/2019","q_eps":null,"a_eps":0.000,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":28,"price":14.610,"returns":92,"ticker":"CLDR","note":"Analysts at Needham Didn't Change their Buy rating for Cloudera (CLDR) with $28 Target Price","to_char":"03/14/2019","q_eps":null,"a_eps":-1.050,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":17,"price":9.770,"returns":76,"ticker":"AKBA","note":"Price Target Summary: Akebia Therapeutics (AKBA) likely to touch $17.29 in 52-week period - Voice Of Analysts","to_char":"03/13/2019","q_eps":null,"a_eps":-1.360,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null}]
